Bisphosphonates Linked With Lower Death Risk After Low-Trauma Break

(MedPage Today) — SEATTLE — Risk of death was lower in the years after a bisphosphonate was started following a fracture rather than denosumab (Prolia), a target trial emulation found.
In adults ages 50 and older who experienced low-trauma…